Companies
Boston Scientific
Medical devicesMarlborough, MassachusettsBSXAbout 59,000 employees
More about Boston Scientific
Medical device company that makes heart, vascular, digestive, urology and neuromodulation devices used in minimally invasive procedures.
Revenue
$20.1B
Fiscal 2025, up about 20%
Employees
About 59,000
As of December 2025
Stock
BSX
New York Stock Exchange
Headquarters
Marlborough, Massachusetts
CEO
Mike Mahoney
Since November 2012
Main businessesCardiovascular (Watchman, Farapulse, interventional cardiology), MedSurg (endoscopy, urology, neuromodulation)
Current strategyStrengthening category leadership, expanding into high-growth adjacencies and global markets, and funding growth through cost programs
Recent workforce changes2026 restructuring plan approved in July 2026 with some headcount reductions, $700M to $800M in charges and about $500M in annual savings expected by 2029
CompetitorsMedtronic, Abbott, Edwards Lifesciences
Related companiesMedtronicAbbottEdwards Lifesciences
Checked October 11, 2026 · Sources: sec.gov, hoodline.com, massdevice.com
No source-backed updates for Boston Scientific yet. They appear here when a public report or filing covers the company.
No one has posted about Boston Scientific yet. Be the first to post ›
Follow Boston Scientific in a feed reader, no account needed: RSS feed